Recruitment to randomised prevention trials is challenging, not least for intracerebral haemorrhage (ICH) associated with antithrombotic drug use. We investigated reasons for not recruiting apparently eligible patients at hospital sites that keep screening logs in the ongoing REstart or STop Antithrombotics Randomised Trial (RESTART), which seeks to determine whether to start antiplatelet drugs after ICH.
Stacey Valentine合作论文数1Hawraman Ramadan合作论文数1Paul Mudd合作论文数1Anthony Byrne合作论文数1Suzanne Ragab合作论文数1Evangelos Vasileiadis合作论文数1Farzana Patel合作论文数1Frances Harrington合作论文数1Ruth Bellfield合作论文数1Amy E. Maxwell合作论文数1Mandy Doherty合作论文数1Melinda Holden合作论文数1Lakshmanan Sekaran合作论文数1Bindu Gregary合作论文数1Amanda Hedstrom合作论文数1
Ingrid Kane合作论文数1Anu Joyson合作论文数1Sharon Tysoe合作论文数1Fiona Price合作论文数1Divya Tiwari合作论文数1Tim England合作论文数1
Mary Joan Macleod合作论文数Inst Med Sci, Univ Aberdeen1
David Leslie Cohen合作论文数1
Keith Muir合作论文数School of Cardiovascular & Metabolic Health, University of Glasgow;Institute of Neuroscience and Psychology, University of Glasgow1
Jonathan Hewitt合作论文数1Owusu-Agyei Peter合作论文数1Anthony Rudd合作论文数Department of Population Health Sciences, School of Life Course & Population Sciences, Faculty of Life Sciences & Medicine, King's College London1Sharon A. Johnson合作论文数Department of Management, Worcester Polytechnic Institute1
Hedley C A Emsley合作论文数University of Manchester;Clinical Sciences Building, Hope Hospital;Hope Hospital, University of Manchester1Mark O. Mccarron合作论文数1
Rustam Al-Shahi Salman合作论文数Centre for Clinical Brain Sciences, The University of Edinburgh;Edinburgh Clinical Trials Unit, The University of Edinburgh;Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh1
